Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Eleven Biotherapeutics, Inc. | 272,580 | reported | 12 Jun 2018 | tx 7+1,303,303 |
| LAVA Therapeutics NV | 0 | reported | 13 Nov 2025 | tx 3+335,100−340,100 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 13 Nov 2025 | OTHER | LAVA Therapeutics NV | 5,000 | — | |
| 13 Nov 2025 | OTHER | LAVA Therapeutics NV | 335,100 | 0.00 USD | deriv |
| 13 Feb 2025 | GRANT_AWARD | LAVA Therapeutics NV | 335,100 | 0.00 USD | deriv |
| 12 Jun 2018 | GRANT_AWARD | Eleven Biotherapeutics, Inc. | 87,150 | 0.00 USD | deriv |
| 09 Apr 2018 | GRANT_AWARD | Eleven Biotherapeutics, Inc. | 250,000 | 0.00 USD | deriv |
| 14 Mar 2018 | GRANT_AWARD | Eleven Biotherapeutics, Inc. | 105,000 | 0.00 USD | deriv |
| 18 Jan 2018 | GRANT_AWARD | Eleven Biotherapeutics, Inc. | 80,430 | 0.00 USD | deriv |
| 03 Apr 2017 | GRANT_AWARD | Eleven Biotherapeutics, Inc. | 32,692 | 0.00 USD | deriv |
| 20 Sept 2016 | GRANT_AWARD | Eleven Biotherapeutics, Inc. | 398,031 | — | |
| 20 Sept 2016 | GRANT_AWARD | Eleven Biotherapeutics, Inc. | 350,000 | 0.00 USD | deriv |